SYNDAX PHARMACEUTICALS INC shareholders Q3 2023

SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 177 filers reported holding SYNDAX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.

SYNDAX PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TWO SIGMA ADVISERS, LP 67,052$973,5950.00%
GEODE CAPITAL MANAGEMENT, LLC 1,360,920$19,763,0290.00%
EXCHANGE TRADED CONCEPTS, LLC 6,028$87,5270.00%
AXIOM INVESTORS LLC /DE 10,820$157,1060.00%
NORTHERN TRUST CORP 635,525$9,227,8230.00%
AMERIPRISE FINANCIAL INC 499,521$7,253,0460.00%
STRS OHIO 27,000$3920.00%
RHUMBLINE ADVISERS 98,969$1,437,0120.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 693,800$10,073,9760.00%
VOYA INVESTMENT MANAGEMENT LLC 48,889$709,8680.00%
Russell Investments Group, Ltd. 18,798$272,9460.00%
JPMORGAN CHASE & CO 729,098$10,586,5030.00%
NEW YORK STATE COMMON RETIREMENT FUND 30,825$4480.00%
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 18,968$275,4150.00%
CREDIT SUISSE AG/ 71,140$1,032,9520.00%
CITIGROUP INC 120,232$1,745,7690.00%
DIMENSIONAL FUND ADVISORS LP 106,140$1,541,1530.00%
SEI INVESTMENTS CO 36,135$524,8290.00%
MORGAN STANLEY 550,029$7,986,4210.00%
AMALGAMATED BANK 9,023$1310.00%
External links

This page lists SYNDAX PHARMACEUTICALS INC's shareholders in Q3 2023. To view SYNDAX PHARMACEUTICALS INC's shareholder history, click here.